Summary & Overview
HCPCS C8937: Breast MRI Computer-Aided Detection with Pharmacokinetic Analysis
HCPCS Level II code C8937 covers computer-aided detection (CAD) applied to breast MRI studies, including algorithmic lesion detection, characterization and pharmacokinetic analysis with further physician review. As an add-on service billed separately from the primary MRI procedure, this code captures advanced quantitative imaging analysis that can augment radiologist interpretation. Nationally, adoption of imaging CAD tools affects imaging workflow, documentation, and billing practices as radiology groups, hospitals and payers evaluate clinical value and appropriate use.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare and Medicare. Readers will find an overview of what C8937 represents clinically and operationally, typical sites of service, and the payer landscape covered in the analysis. The publication provides benchmarks on utilization and reimbursement patterns, summaries of relevant policy and coverage considerations, and clinical context regarding the role of CAD and pharmacokinetic analysis in breast MRI interpretation.
The content is intended for national audiences including radiology administrators, billing professionals, and policy analysts seeking concise guidance on coding, billing implications and how payers approach coverage for adjunctive computer-aided breast MRI services. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code C8937 describes computer-aided detection for breast MRI, specifically computer algorithm analysis of breast MRI image data for lesion detection and characterization, including pharmacokinetic analysis, with subsequent physician review for interpretation. This service is reported in addition to the primary procedure when the computer-aided detection is performed alongside the diagnostic MRI.
-
Service type: Advanced imaging adjunct (computer-aided detection/quantitative imaging analysis)
-
Typical site of service: Imaging center or hospital outpatient department where breast MRI studies are performed
Clinical & Coding Specifications
Clinical Context
A 52-year-old woman with a personal history of atypical ductal hyperplasia and a new palpable right breast mass is referred for contrast-enhanced breast MRI to further evaluate extent of disease and to assess for additional lesions not seen on mammography and ultrasound. During the MRI study, a computer-aided detection algorithm is applied to the breast MRI image dataset to perform lesion detection, pharmacokinetic (contrast wash-in/wash-out) analysis, and preliminary lesion characterization. A board-certified radiologist performs image acquisition supervision, reviews the algorithm output, integrates the CAD findings with raw MR sequences (including T1-weighted dynamic contrast-enhanced series and subtraction images), documents correlated imaging features, and issues a final interpretation and recommendation.
Typical clinical workflow:
-
Patient arrives to an outpatient radiology or breast imaging center and completes screening safety and contrast consent.
-
MRI technologist performs contrast-enhanced breast MRI sequences with standardized dynamic protocols and uploads datasets to the PACS and to the CAD workstation.
-
The CAD software processes the DICOM MRI series, performs pharmacokinetic modeling, highlights regions of interest, and generates quantitative outputs (kinetic curves, lesion volumes, enhancement maps) for physician review.
-
The interpreting radiologist reviews native and post-processed images, evaluates CAD-identified targets, confirms or refutes CAD findings, incorporates clinical history, and documents the final report. The CAD service is billed in addition to the primary MRI procedure using billing code
C8937.